Autoantibody-Associated Movement Disorders in Children: Proven and Proposed

Martino, 2009, Immunopathogenic mechanisms in Tourette syndrome: A critical review, Mov Disord, 24, 1267, 10.1002/mds.22504 Mohammad, 2013, Autoantibody-associated movement disorders, Neuropediatrics, 44, 336, 10.1055/s-0033-1358603 Graus, 2016, A clinical approach to diagnosis of autoimmune encephalitis, Lancet Neurol, 15, 391, 10.1016/S1474-4422(15)00401-9 Dalmau, 2007, Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050 Hartley, 2002, Immune mediated chorea encephalopathy syndrome in childhood, Dev Med Child Neurol, 44, 273, 10.1017/S0012162201002055 Dale, 2004, Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity, Brain, 127, 21, 10.1093/brain/awh008 Sebire, 1992, Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: An acute encephalopathy of obscure origin, J Pediatr, 121, 845, 10.1016/S0022-3476(05)80326-9 Dale, 2009, N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica, Ann Neurol, 66, 704, 10.1002/ana.21807 Dalmau, 2008, Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2 Hughes, 2010, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis, J Neurosci, 30, 5866, 10.1523/JNEUROSCI.0167-10.2010 Pruss, 2012, N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis, Ann Neurol, 72, 902, 10.1002/ana.23689 Armangue, 2013, Pediatric anti-N-methyl-d-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients, J Pediatr, 162, 850-856.e2, 10.1016/j.jpeds.2012.10.011 Yushvayev-Cavalier, 2015, Possible autoimmune association between herpes simplex virus infection and subsequent anti-N-methyl-d-aspartate receptor encephalitis: A pediatric patient with abnormal movements, Pediatr Neurol, 52, 454, 10.1016/j.pediatrneurol.2014.10.011 Brenton, 2016, Approach to the management of pediatric-onset anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis: A case series, J Child Neurol, 31, 1150, 10.1177/0883073816643406 Hacohen, 2014, N-methyl-d-aspartate receptor antibody-associated movement disorder without encephalopathy, Dev Med Child Neurol, 56, 190, 10.1111/dmcn.12321 Baizabal-Carvallo, 2013, The spectrum of movement disorders in children with anti-NMDA receptor encephalitis, Mov Disord, 28, 543, 10.1002/mds.25354 Mohammad, 2014, Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies, Mov Disord, 29, 1539, 10.1002/mds.25999 Lebas, 2010, Expanding spectrum of encephalitis with NMDA receptor antibodies in young children, J Child Neurol, 25, 742, 10.1177/0883073809343319 Kleinig, 2008, The distinctive movement disorder of ovarian teratoma-associated encephalitis, Mov Disord, 23, 1256, 10.1002/mds.22073 Poewe, 2015, Movement disorders in systemic diseases, Neurol Clin, 33, 269, 10.1016/j.ncl.2014.09.015 Panzer, 2011, Movement disorders in paraneoplastic and autoimmune disease, Curr Opin Neurol, 24, 346, 10.1097/WCO.0b013e328347b307 Titulaer, 2013, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study, Lancet Neurol, 12, 157, 10.1016/S1474-4422(12)70310-1 Maat, 2013, Psychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodies, Acta Neuropsychiatr, 25, 128, 10.1111/acn.12013 Spatola, 2017, Investigations in GABAA receptor antibody-associated encephalitis, Neurology, 88, 1012, 10.1212/WNL.0000000000003713 Waters, 2017, G2A1B3AA receptor antibodies and their clinical associations, Neurology, 88, 1010, 10.1212/WNL.0000000000003758 Kruer, 2014, Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: The first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity, JAMA Neurol, 71, 620, 10.1001/jamaneurol.2013.4786 Golombeck, 2016, Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis, Neurol Neuroimmunol Neuroinflamm, 3, e232, 10.1212/NXI.0000000000000232 Hutchinson, 2008, Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody, Neurology, 71, 1291, 10.1212/01.wnl.0000327606.50322.f0 Mas, 2011, Antiglycine-receptor encephalomyelitis with rigidity, J Neurol Neurosurg Psychiatry, 82, 1399, 10.1136/jnnp.2010.229104 Carvajal-Gonzalez, 2014, Glycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomes, Brain, 137, 2178, 10.1093/brain/awu142 Hacohen, 2013, Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens, J Neurol Neurosurg Psychiatry, 84, 748, 10.1136/jnnp-2012-303807 Damasio, 2013, Progressive encephalomyelitis with rigidity and myoclonus: The first pediatric case with glycine receptor antibodies, JAMA Neurol, 70, 498, 10.1001/jamaneurol.2013.1872 Chan, 2017, Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children, Eur J Paediatr Neurol, 21, 414, 10.1016/j.ejpn.2016.08.013 Hacohen, 2015, Clinical relevance of voltage-gated potassium channel-complex antibodies in children, Neurology, 85, 967, 10.1212/WNL.0000000000001922 Bastiaansen, 2017, Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies), Curr Opin Neurol, 30, 302, 10.1097/WCO.0000000000000444 van Sonderen, 2017, The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis, Nat Rev Neurol, 13, 290, 10.1038/nrneurol.2017.43 Irani, 2011, Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis, Ann Neurol, 69, 892, 10.1002/ana.22307 Irani, 2013, Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype, Brain, 136, 3151, 10.1093/brain/awt212 Tan, 2009, MELAS syndrome, diabetes and thyroid disease: The role of mitochondrial oxidative stress, Clin Endocrinol, 70, 340, 10.1111/j.1365-2265.2008.03341.x Tofaris, 2012, Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis, Neurology, 79, 195, 10.1212/WNL.0b013e31825f0522 Balint, 2014, Progressive encephalomyelitis with rigidity and myoclonus: A new variant with DPPX antibodies, Neurology, 82, 1521, 10.1212/WNL.0000000000000372 Dale, 2012, Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders, Brain, 135, 3453, 10.1093/brain/aws256 Faria, 2017, Neuropsychiatric systemic lupus erythematosus involvement: Towards a tailored approach to our patients?, Rambam Maimonides Med J, 8, e0001, 10.5041/RMMJ.10276 Mrabet, 2015, Mixed movements disorders as an initial feature of pediatric lupus, Brain Dev, 37, 904, 10.1016/j.braindev.2015.01.008 Lythgoe, 2017, Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: A longitudinal analysis, Lupus, 26, 10.1177/0961203317700484 von Scheven, 1996, Clinical characteristics of antiphospholipid antibody syndrome in children, J Pediatr, 129, 339, 10.1016/S0022-3476(96)70064-1 Paley, 2017, From mechanism to therapies in systemic lupus erythematosus, Curr Opin Rheumatol, 29, 178, 10.1097/BOR.0000000000000369 Wright, 2017, Paediatric systemic lupus erythematosus: Insights from translational research, Rheumatology (Oxford), 56, i24, 10.1093/rheumatology/kew447 Galanaud, 2000, Brain MRI in patients with past lupus-associated chorea, Stroke, 31, 3079, 10.1161/01.STR.31.12.3079-b Krakauer, 2009, FDG PET brain imaging in neuropsychiatric systemic lupus erythematosis with choreic symptoms, Clin Nucl Med, 34, 122, 10.1097/RLU.0b013e318192c4d2 Meroni, 2011, Pathogenesis of antiphospholipid syndrome: Understanding the antibodies, Nat Rev Rheumatol, 7, 330, 10.1038/nrrheum.2011.52 Yelnik, 2016, Non-stroke central neurologic manifestations in antiphospholipid syndrome, Curr Rheumatol Rep, 18, 11, 10.1007/s11926-016-0568-x Cervera, 2017, Antiphospholipid syndrome, Thromb Res, 151, S43, 10.1016/S0049-3848(17)30066-X Rumsey, 2017, Diagnosis and treatment of antiphospholipid syndrome in childhood: A review, Blood Cells Mol Dis, 10.1016/j.bcmd.2017.02.009 Abreu, 2015, The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features, Autoimmun Rev, 14, 401, 10.1016/j.autrev.2015.01.002 Freeman, 2014, Fitting and flailing: Recognition of paediatric antiphospholipid syndrome, Arch Dis Child Educ Pract Ed, 99, 28, 10.1136/archdischild-2012-302404 Baizabal-Carvallo, 2013, Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome, J Neural Transm (Vienna), 120, 1579, 10.1007/s00702-013-1023-z Peluso, 2012, Antiphospholipid-related chorea, Front Neurol, 3, 150, 10.3389/fneur.2012.00150 Graham, 2016, Hashimoto encephalopathy presenting with stroke-like episodes in an adolescent female: A case report and literature review, Pediatr Neurol, 59, 62, 10.1016/j.pediatrneurol.2016.02.003 Nandi-Munshi, 2015, Thyroid-related neurological disorders and complications in children, Pediatr Neurol, 52, 373, 10.1016/j.pediatrneurol.2014.12.005 Montagna, 2016, Hashimoto's encephalopathy: A rare proteiform disorder, Autoimmun Rev, 15, 466, 10.1016/j.autrev.2016.01.014 Cook, 2015, The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature, J Clin Apher, 30, 188, 10.1002/jca.21353 Rodriguez, 2006, EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy), J Clin Neurophysiol, 23, 371, 10.1097/01.wnp.0000214542.21735.49 Shaw, 1991, Hashimoto's encephalopathy: A steroid-responsive disorder associated with high anti-thyroid antibody titers—Report of 5 cases, Neurology, 41, 228, 10.1212/WNL.41.2_Part_1.228 Alink, 2008, Unexplained seizures, confusion or hallucinations: Think Hashimoto encephalopathy, Acta Paediatr, 97, 451, 10.1111/j.1651-2227.2008.00686.x Hilberath, 2014, Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Case report of reversible coma and status epilepticus in an adolescent patient and review of the literature, Eur J Pediatr, 173, 1263, 10.1007/s00431-014-2391-6 Oosterveer, 2010, Sydenham's chorea: A practical overview of the current literature, Pediatr Neurol, 43, 1, 10.1016/j.pediatrneurol.2009.11.015 Cardoso, 2011, Sydenham's chorea, Handb Clin Neurol, 100, 221, 10.1016/B978-0-444-52014-2.00014-8 Moreira, 2014, Psychiatric disorders in persistent and remitted Sydenham's chorea, Parkinsonism Relat Disord, 20, 233, 10.1016/j.parkreldis.2013.10.029 de Teixeira, 2009, Frequency and significance of vocalizations in Sydenham's chorea, Parkinsonism Relat Disord, 15, 62, 10.1016/j.parkreldis.2008.01.014 Hallett, 2015, Where does chorea come from? cortical excitability findings challenge classic pathophysiological concepts, Mov Disord, 30, 169, 10.1002/mds.26109 Khedr, 2015, Changes in motor cortical excitability in patients with Sydenham's chorea, Mov Disord, 30, 259, 10.1002/mds.25928 Husby, 1976, Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever, J Exp Med, 144, 1094, 10.1084/jem.144.4.1094 Church, 2002, Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea, Neurology, 59, 227, 10.1212/WNL.59.2.227 Kirvan, 2003, Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea, Nat Med, 9, 914, 10.1038/nm892 Kirvan, 2006, Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea, Autoimmunity, 39, 21, 10.1080/08916930500484757 Kirvan, 2006, Antibody-mediated neuronal cell signaling in behavior and movement disorders, J Neuroimmunol, 179, 173, 10.1016/j.jneuroim.2006.06.017 Cunningham, 2016, Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: A review of Sydenham chorea and beyond, Acta Physiol (Oxf), 216, 90, 10.1111/apha.12614 Kirvan, 2007, Tubulin is a neuronal target of autoantibodies in Sydenham's chorea, J Immunol, 178, 7412, 10.4049/jimmunol.178.11.7412 Ben-Pazi, 2013, Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea, PLoS One, 8, e73516, 10.1371/journal.pone.0073516 Brimberg, 2012, Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders, Neuropsychopharmacology, 37, 2076, 10.1038/npp.2012.56 Cox, 2013, Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: Implications in human disease, J Immunol, 191, 5524, 10.4049/jimmunol.1102592 Brilot, 2011, Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome, Neurology, 76, 1508, 10.1212/WNL.0b013e3182181090 Ben-Pazi, 2012, Striatal microinjection of Sydenham chorea antibodies: Using a rat model to examine the dopamine hypothesis, J Mol Neurosci, 46, 162, 10.1007/s12031-011-9559-6 Lotan, 2014, Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats, Brain Behav Immun, 38, 249, 10.1016/j.bbi.2014.02.009 Yaddanapudi, 2010, Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection, Mol Psychiatry, 15, 712, 10.1038/mp.2009.77 Dean, 2017, Treatment of Sydenham's chorea: A review of the current evidence, Tremor Other Hyperkinet Disord, 7, 456, 10.5334/tohm.376 Swedo, 1998, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases, Am J Psychiatry, 155, 264, 10.1176/ajp.155.2.264 Chang, 2015, Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference, J Child Adolesc Psychopharmacol, 25, 3, 10.1089/cap.2014.0084 Orefici, 2016, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) Morer, 2005, D8/17 monoclonal antibody: An unclear neuropsychiatric marker, Behav Neurol, 16, 1, 10.1155/2005/795343 Giedd, 2000, MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection, Am J Psychiatry, 157, 281, 10.1176/appi.ajp.157.2.281 Kumar, 2015, Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: A positron emission tomographic (PET) study using 11C-[R]-PK11195, J Child Neurol, 30, 749, 10.1177/0883073814543303 Singer, 2012, Moving from PANDAS to CANS, J Pediatr, 160, 725, 10.1016/j.jpeds.2011.11.040 Singer, 2000, Infection: A stimulus for tic disorders, Pediatr Neurol, 22, 380, 10.1016/S0887-8994(00)00131-4 Leckman, 2011, Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: A prospective longitudinal study, J Am Acad Child Adolesc Psychiatry, 50, 108, 10.1016/j.jaac.2010.10.011 Shet, 2002, Clinical use and interpretation of group A streptococcal antibody tests: A practical approach for the pediatrician or primary care physician, Pediatr Infect Dis J, 21, 420, 10.1097/00006454-200205000-00014 Gabbay, 2008, Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: Comparison of diagnosis and treatment in the community and at a specialty clinic, Pediatrics, 122, 273, 10.1542/peds.2007-1307 Helm, 2015, Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS): Experience at a tertiary referral center, Tremor Other Hyperkinet Mov, 5, 270, 10.5334/tohm.243 Kurlan, 2004, The PANDAS hypothesis: Losing its bite?, Mov Disord, 19, 371, 10.1002/mds.20107 Kaplan, 1998, Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States, Pediatrics, 101, 86, 10.1542/peds.101.1.86 Kurlan, 2008, Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study, Pediatrics, 121, 1188, 10.1542/peds.2007-2657 Perrin, 2004, Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?, Arch Pediatr Adolesc Med, 158, 848, 10.1001/archpedi.158.9.848 Mell, 2005, Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder, Pediatrics, 116, 56, 10.1542/peds.2004-2058 Leslie, 2008, Neuropsychiatric disorders associated with streptococcal infection: A case-control study among privately insured children, J Am Acad Child Adolesc Psychiatry, 47, 1166, 10.1097/CHI.0b013e3181825a3d Schrag, 2009, Streptococcal infection, Tourette syndrome, and OCD: Is there a connection?, Neurology, 73, 1256, 10.1212/WNL.0b013e3181bd10fd Pavone, 2014, Pediatric autoimmune neuropsychiatric disorder associated with group a streptococcal infection: The role of surgical treatment, Int J Immunopathol Pharmacol, 27, 371, 10.1177/039463201402700307 Demesh, 2015, The role of tonsillectomy in the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), JAMA Otolaryngol Head Neck Surg, 141, 272, 10.1001/jamaoto.2014.3407 Windfuhr, 2016, Tonsillectomy remains a questionable option for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). GMS Curr Top Otorhinolaryngol, Head Neck Surg, 15 Garvey, 1999, A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections, Biol Psychiatry, 45, 1564, 10.1016/S0006-3223(99)00020-7 Snider, 2005, Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders, Biol Psychiatry, 57, 788, 10.1016/j.biopsych.2004.12.035 Perlmutter, 1999, Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood, Lancet, 354, 1153, 10.1016/S0140-6736(98)12297-3 Kovacevic, 2015, Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, J Child Adolesc Psychopharmacol, 25, 65, 10.1089/cap.2014.0067 Williams, 2016, Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, J Am Acad Child Adolesc Psychiatry, 55, 860, 10.1016/j.jaac.2016.06.017 Latimer, 2015, Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, J Child Adolesc Psychopharmacol, 25, 70, 10.1089/cap.2014.0080 Church, 2003, Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis, J Neurol Neurosurg Psychiatry, 74, 602, 10.1136/jnnp.74.5.602 Dale, 2006, Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease, J Neuroimmunol, 172, 187, 10.1016/j.jneuroim.2005.10.014 Singer, 2005, Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls, Neurology, 65, 1701, 10.1212/01.wnl.0000183223.69946.f1 Singer, 2008, Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, Pediatrics, 121, 1198, 10.1542/peds.2007-2658 Pavone, 2004, Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection, Pediatr Neurol, 30, 107, 10.1016/S0887-8994(03)00413-2 Morris, 2009, Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls, J Neurol Sci, 276, 45, 10.1016/j.jns.2008.08.032 Morris-Berry, 2013, Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments, J Neuroimmunol, 264, 106, 10.1016/j.jneuroim.2013.09.010 Singer, 2015, Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection, PLoS One, 10, e0120499, 10.1371/journal.pone.0120499 Loiselle, 2004, Striatal microinfusion of Tourette syndrome and PANDAS sera: Failure to induce behavioral changes, Mov Disord, 19, 390, 10.1002/mds.10522